Skip to main content
. 2012 Jul 16;75(2):507–521. doi: 10.1111/j.1365-2125.2012.04381.x

Figure 1.

Figure 1

Mean (SD) plasma concentration (ng ml−1)−time (h) curve in log-linear scale following intravenous administration of eribulin mesylate alone (1.4 mg m−2; n = 11) or eribulin mesylate (1.4 mg m−2) with rifampicin (600 mg; n = 11 both groups). A) time scale up to 150 h, B) time scale up to 6 h. Inline graphic, Eribulin only; Inline graphic, Eribulin plus rifampicin